Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,902 | -76,723 | 127,840 | -166,183 | -107,778 |
| Depreciation Amortization | 7,912 | 4,051 | 15,406 | 11,335 | 7,001 |
| Accounts receivable | -5,028 | 5,689 | 14,118 | -7,886 | -1,484 |
| Accounts payable and accrued liabilities | 9,527 | 16,755 | -2,304 | 6,503 | -847 |
| Other Working Capital | -2,812 | 6,044 | 40,218 | -1,888 | -3,316 |
| Other Operating Activity | 17,643 | -11,727 | 23,597 | 35,497 | 26,305 |
| Operating Cash Flow | $-117,660 | $-55,911 | $218,875 | $-122,622 | $-80,119 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -71,468 | -79,624 | -322,467 | -120,722 | -155,521 |
| PPE Investments | -20,204 | -10,967 | -84,175 | -69,561 | -50,863 |
| Investing Cash Flow | $-91,672 | $-90,591 | $-406,642 | $-190,283 | $-206,384 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,466 | 959 | 222,487 | 221,502 | 218,632 |
| Other Financing Activity | -16,969 | -7,793 | -27,237 | -18,636 | -13,483 |
| Financing Cash Flow | $-14,503 | $-6,834 | $195,250 | $202,866 | $205,149 |
| Beginning Cash Position | 347,239 | 347,239 | 339,756 | 339,756 | 339,756 |
| End Cash Position | 123,404 | 193,903 | 347,239 | 229,717 | 258,402 |
| Net Cash Flow | $-223,835 | $-153,336 | $7,483 | $-110,039 | $-81,354 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,660 | -55,911 | 218,875 | -122,622 | -80,119 |
| Capital Expenditure | -20,204 | -10,967 | -84,175 | -69,561 | -50,863 |
| Free Cash Flow | -137,864 | -66,878 | 134,700 | -192,183 | -130,982 |